BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2010
View Archived Issues
Cequent describes IND-enabling studies of RNAi drug for adenomatous polyposis
Read More
Vascular Biogenics (d/b/a VBL Therapeutics) discloses novel antiinflammatory agents
Read More
Antihypertensive efficacy of azilsartan medoxomil demonstrated in multiple studies
Read More
Argenta Oral Therapeutics claims dual CRTH2/DP receptor ligands
Read More
Next-generation sequencing analysis identifies gene mutations affecting response to panitumumab
Read More
Sirtuin expression linked to non-small cell lung cancer
Read More
Merck & Co. identifies novel histamine H3 receptor ligands
Read More
Chinese scientists claim novel anti-HIV akaloids
Read More
Palau Pharma presents novel histamine H4 receptor antagonists
Read More
Dual PDK1/AKT inhibitor PHT-427 identified through PHuDock platform
Read More
Novel LNA-based antisense oligonucleotides show potent antitumor effects in vivo
Read More
Intercell acquires monoclonal antibody discovery platform from Cytos
Read More
Stemgent and Miltenyi Biotec form strategic stem cell partnership
Read More
MediGene reports results from phase II clinical trial of EndoTAG-1 in breast cancer
Read More
Eisai to initiate phase III trial of rufinamide in Lennox-Gastaut syndrome in Japan
Read More
Dynavax completes first immunizations in phase III study of Heplisav
Read More
Polyphor enters into PEMfinder collaboration with Novartis
Read More
Long-lasting effects seen with NGX-4010 in postherpetic neuralgia patients
Read More
VX-222 development for hepatitis C advances
Read More
Bayer Schering Pharma begins phase III regorafenib trial in mCRC
Read More
Aeterna Zentaris receives FDA orphan drug status for AEZS-108 in ovarian cancer
Read More
Meda acquires exclusive rights to flupirtine for fibromyalgia
Read More
Improvements seen with gene therapy in small study in severe retinal dystrophy
Read More
Oramed reports results for phase IIb trial of oral insulin in type 2 diabetes
Read More
Alzheimer's Drug Discovery Foundation funds chaperone technology
Read More
New FDA dosing guidelines for colchicine given with protease inhibitors
Read More
ThromboGenics and BioInvent VTE treatment deemed superior to standard treatment
Read More